View Full Version : Anyone Heard of this Drug
tracey2424
02-13-2008, 09:32 AM
I have found out the name of the frug ny onc wants me to start in a clinical trial its called (Eribulin Mesylate) any info on this would be greatly appreciated it has been ongoing in the US for sometime in phase 1+2 trials.
What i really want to know is will i loose my hair again i really am dreading this its only just coming back.
Not sure whether to just go back to Xelodia which was very tolerable.
This is such a hard decision it really is getting me down.
Advice needed.
Tracey.
http://meeting.ascopubs.org/cgi/content/abstract/25/18_suppl/7546
Novel Agents for Advanced Breast Cancer
Several abstracts described new agents in development for the treatment of refractory breast cancer. Eribulin mesylate is a synthetic analog of halichondrin B, a microtubule inhibitor. A phase 2 study[7] analyzed the effect of eribulin mesylate in chemotherapy-refractory metastatic breast cancer. In this trial of approximately 100 women, there was an average of 5 prior chemotherapy regimens (including adjuvant treatment). The overall response rate was 11%. A slightly higher response rate was seen in women treated on a 2-weeks-on, 1-week-off schedule, compared with the 3-weeks-on, 1-week-off schedule. Neutropenia was the major grade 3 or 4 toxicity, though 5% of patients also had grade 3 neuropathy.
Also--
http://pubs.acs.org/cen/business/85/8541bus1box.html
and
http://www.foxbusiness.com/markets/industries/health-care/article/eisai-announces-change-submission-schedule-e7389-new-drug-application_461024_10.html
BonnieR
02-13-2008, 10:48 AM
Sounds like you have alot of questions for your oncologist so you can make an informed decision.
I remember when I was dreading hair loss, my oncologist simply said "it grows back". And as sad as it was to loose my hair, she was right of course. It is a reversible part of the process.
Let us know what you decide...
vBulletin® v3.8.7, Copyright ©2000-2026, vBulletin Solutions, Inc.